Cutting edge: Nonobese diabetic mice deficient in chromogranin a are protected from autoimmune diabetes

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 39-43

  Baker, Rocky L ^a,b   Bradley, Brenda ^a,b   Wiles, Timothy A ^a,b   Lindsay, Robin S ^a,b   Barbour, Gene ^a,b   Delong, Thomas ^a,b   Friedman, Rachel S ^a,b   Haskins, Kathryn ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; AUTOANTIGEN; CHROMOGRANIN A, MOUSE; MICROSATELLITE DNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; ADOPTIVE TRANSFER; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHROMOGRANIN A; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; ISLETS OF LANGERHANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICROSATELLITE REPEATS;

EID: 84953317106     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501190     Document Type: Article

References (19)

1. Stadinski, B. D., T. Delong, N. Reisdorph, R. Reisdorph, R L. Powell, M. Armstrong, J. D. Piganelli, G. Barbour, B. Bradley, F. Crawford, et al. 2010. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11: 225-231
2. Gottlieb, P. A., T. Delong, R L. Baker, L. Fitzgerald-Miller, R. Wagner, G. Cook, M. R Rewers, A. Michels, and K. Haskins. 2014. Chromogranin A is a T cell antigen in human type 1 diabetes. J. Autoimmun. 50: 38-41.
3. Delong, T., R. L. Baker, J. He, G. Barbour, B. Bradley, and K. Haskins. 2012. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A. Diabetes 61: 3239-3246.
4. Baker, R. L., T. Delong, G. Barbour, B. Bradley, M. Nakayama, and K. Haskins. 2013. Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice. J. Immunol. 191: 3990-3994.
5. Yamamoto, T., E. Yamato, F. Tashiro, T. Sato, S. Noso, H. Ikegami, S. Tamura, Y. Yanagawa, and J.-I. Miyazaki. 2004. Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia 47: 221-224.
6. Kubosaki, A., J. Miura, and A. L. Notkins. 2004. IA-2 is not required for the development of diabetes in NOD mice. Diabetologia 47: 149-150.
7. Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D. R. Wegmann, J. C. Hutton, J. F. Elliott, and G. S. Eisenbarth. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223.
8. Mahapatra, N. R., D. T. O'Connor, S. M. Vaingankar, A. P. S. Hikim, M. Mahata, S. Ray, E. Stake, H. Wu, Y. Gu, N. Dalton, et al. 2005. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J. Clin. Invest. 115: 1942-1952.
9. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Celll 74: 1089-1100.
10. Pauza, M. E., C. M. Dobbs, J. He, T. Patterson, S. Wagner, B. S. Anobile, B. J. Bradley, D. Lo, and K. Haskins. 2004. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 53: 978-988.
11. Haskins, K., M. Portas, B. Bergman, K. Lafferty, and B. Bradley. 1989. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 86: 8000-8004.
12. Friedman, R. S., R. S. Lindsay, J. K. Lilly, V. Nguyen, C. M. Sorensen, J. Jacobelli, and M. F. Krummel. 2014. An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function. Proc. Natl. Acad. Sci. USA 111: 9223-9228.
13. Soyfoo, M. S., S. Steinfeld, and C. Delporte. 2007. Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome. Oral Dis. 13: 366-375
14. Wu, C, I. Macleod, and A. I. Su. 2013. BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 41: D561-D565
15. Stratmann, T., N. Martin-Orozco, V. Mallet-Designe, L. Poirot, D. McGavern, G. Losyev, C. M. Dobbs, M. B. A. Oldstone, K. Yoshida, H. Kikutani, et al. 2003. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 112: 902-914.
16. + T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc. Natl. Acad. Sci. USA 108: 16729-16734.
17. Daniel, D., R. G. Gill, N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062.
18. Alkemade, G. M., X. Clemente-Casares, Z. Yu, B.-Y. Xu, J. Wang, S. Tsai, J. R Wright, Jr., B. O. Roep, and P. Santamaria. 2013. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts. Diabetes 62: 905-911
19. Lutterotti, A., S. Yousef, A. Sputtek, K. H. Stiirner, J.-P. Stellmann, P. Breiden, S. Reinhardt, C. Schulze, M. Bester, C. Heesen, et al. 2013. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci. Transl. Med. 5: 188ra75